{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-059761","form_type":"8-K","ticker":"ZVIA","cik":"0001854139","company_name":"Zevia PBC","filed_at":"2023-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.075172+00:00","generated_at":"2026-06-08T17:26:48.786719+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Zevia Q3 net sales down 2.6% to $43.1M; net loss widens to $11.3M","bullets":["Net sales $43.1M vs $44.2M YoY; unit volume down 8.2% to 3.3M cases.","Gross margin improved to 45.4% (+2.1pp); net loss $11.3M ($0.16/sh) vs $9.2M loss.","Adjusted EBITDA loss $9.1M vs $2.1M loss a year ago; selling & marketing costs surged.","FY 2023 net sales guidance narrowed to $165M-$168M; Q4 projected $36M-$39M.","Cash $38.5M, no debt; supply chain logistics challenges cited for volume decline."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-059761","json":"https://secwatch.observer/filing/0000950170-23-059761.json","markdown":"https://secwatch.observer/filing/0000950170-23-059761.md","text":"https://secwatch.observer/filing/0000950170-23-059761.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1854139/000095017023059761/0000950170-23-059761-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1854139/000095017023059761/zvia-20231107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T17:26:48.786719+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a1448edbec8a3d35736ca3840affe387b606338c","claim":"Zevia PBC reported third quarter ended September 30, 2023 results: revenue $43.1 million, net income $11.3 million, EPS $0.16 per diluted share.","evidence_excerpt":"Net sales decreased 2.6% year over year to $43.1 million • Unit volume decreased 8.2% year over year to 3.3 million equivalized cases • Gross profit margin was 45.4%, up 2.1 percentage points year over year • Net loss was $11.3 million, including $1.9 million of non-cash equity-based compensation expense • Adjusted EBITDA loss was $9.1 million (1) • Loss per share was $0.16 per diluted share to Zevia’s Class A Common stockholders","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1854139/000095017023059761/0000950170-23-059761-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2023"},{"label":"Revenue","value":"$43.1 million"},{"label":"Net income","value":"$11.3 million"},{"label":"EPS","value":"$0.16 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}